{"disease":{"id":"acute-leukemia-category","name":"acute leukemia category"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT00914628","title":"Efficacy Study on the Strategy of HSV-Tk Engineering Donor Lymphocytes to Treat Patients With High Risk Acute Leukemia","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":92,"lead_sponsor_name":"AGC Biologics S.p.A.","has_results":true},{"nct_id":"NCT03047993","title":"Glutaminase Inhibitor CB-839 and Azacitidine in Treating Patients With Advanced Myelodysplastic Syndrome","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":28,"lead_sponsor_name":"M.D. Anderson Cancer Center","has_results":true}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}